Conmed earnings were $132.4M for the trailing 12 months ending Dec 31, 2024, with 104.3% growth year over year. The latest CNMD earnings report on Dec 31, 2024 announced Q4 2024 earnings of $33.8M, down 31.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CNMD reported annual earnings of $132.4M, with 105.4% growth.
CNMD past earnings growth
How has CNMD's earnings growth performed historically?
On CNMD's earnings call on Invalid Date, Conmed (NYSE: CNMD) reported Q4 2024 earnings per share (EPS) of $1.09, up 0.93% year over year. Total CNMD earnings for the quarter were $33.76 million. In the same quarter last year, Conmed's earnings per share (EPS) was $1.08.
As of the last Conmed earnings report, Conmed is currently profitable. Conmed's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $132.42 million, a 105.44% increase year over year.
What was CNMD's earnings growth in the past year?
As of Conmed's earnings date in Invalid Date, Conmed's earnings has grown 104.29% year over year. This is 55.8 percentage points higher than the US Medical Devices industry earnings growth rate of 48.48%. CNMD earnings in the past year totalled $132.42 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.